3186 results for «300676»
3186 results
TAVI in bicuspid: all you need to know
22 May 2025 – From EuroPCR 2025
Understand the unique anatomical and clinical challenges of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valves. This session covers bicuspid valve epidemiology, indications for surgery and TAVI, and detailed discussion on sizing and deployment fundamentals specific to bicuspid anatomy to optimize procedural success.
Challenging session in calcified lesions
22 May 2025 – From EuroPCR 2025
Engage with a challenging session focused on complex calcified lesion interventions. Topics include innovative triple burr techniques, OCT insights into resistant lesions, volume reduction strategies, eccentric calcium management, and IVUS-guided left main calcified lesion treatment, highlighting practical approaches to difficult cases.
Leaflet modification to prevent coronary obstruction during TAVI
22 May 2025 – From EuroPCR 2025
This session addresses advanced leaflet modification techniques to prevent coronary obstruction during TAVI. Learn from detailed cases involving valve-in-valve interventions, treatment of failed stentless valves, homograft management, and dedicated devices for leaflet modification prior to valve-in-valve and valve-in-valve-in-valve procedures.
Shock and PCI: due to ECMO I survived
22 May 2025 – From EuroPCR 2025
Explore life-saving strategies in the management of cardiogenic shock complicating PCI, with emphasis on ECMO utilization. This session reviews challenging cardiac arrest cases, multi-culprit STEMI scenarios, and innovative STEMI treatments in critical patients, illustrating how ECMO support can be pivotal in survival and recovery.
Management of complex left main trifurcation lesion
22 May 2025 – From EuroPCR 2025
This session focuses on the management of complex left main trifurcation lesions. Review hybrid and double TAP techniques, long-term follow-up outcomes, and innovative approaches such as the inverted double TAP technique, offering insights into optimizing treatment strategies for these challenging anatomical scenarios.
Challenging tricuspid TEER cases
22 May 2025 – From EuroPCR 2025
Explore challenging tricuspid transcatheter edge-to-edge repair (TEER) cases highlighting combined LAA occlusion and mitral valve repair, anatomical complexities, and strategies to complete surgical interventions percutaneously. Discuss the balance between procedural perfection and clinical practicality in complex valve anatomies.
Troubleshooting and management communication in LAA closure
22 May 2025 – From EuroPCR 2025
This session provides comprehensive guidance on troubleshooting and communication during left atrial appendage (LAA) closure procedures. Covering device migration management, transeptal puncture in high bleeding risk patients, scoliosis adaptations, and advanced catheter techniques, it emphasizes practical solutions for procedural complications.
Clinical impact of mechanical circulatory support
22 May 2025 – From EuroPCR 2025
Explore the clinical impact of mechanical circulatory support through a series of detailed presentations covering protocols and training effects on outcomes in left-sided micro-axial flow-supported shock patients, practice variations between Sweden and the U.S., six-month outcomes post coronary intervention with VA-ECMO, and the prognostic value of...
Complication management during mitral TEER procedures
21 May 2025 – From EuroPCR 2025
Explore complex case scenarios of complication management during mitral TEER procedures. This session covers haemodynamic challenges, thrombotic events, device malfunctions, and rare embolisation incidents, providing practical insights into effective bailout techniques and procedural problem-solving.
Treatment dilemmas in STEMI patients with multivessel disease
21 May 2025 – From EuroPCR 2025
Address treatment dilemmas in STEMI patients with multivessel disease through this session focused on imaging and physiology-guided revascularisation strategies. Learn optimal approaches for cases with CABG indications, and timing considerations for non-culprit vessel revascularisation during hospital admission or later stages, supported by illustrative clinical cases.
TAVI for aortic regurgitation: on-label and off-label use
21 May 2025 – From EuroPCR 2025
This session reviews on-label and off-label applications of transcatheter aortic valve implantation (TAVI) for treating aortic regurgitation. Examine complex cases including TAVI in patients with aortic dissection, cardiogenic shock, and valve-in-valve interventions, highlighting innovative procedural approaches and bailout strategies.
Stent technologies, last evidence in coronary interventions
21 May 2025 – From EuroPCR 2025
Update your knowledge on the latest stent technologies and clinical evidence in coronary interventions. This session reviews long-term outcomes of resorbable magnesium scaffolds, seven-year data from the COMPARE-ABSORB trial, bioadaptor versus stent comparisons, dual therapy sirolimus-eluting versus biolimus-eluting stents, and randomized trials on direct stenting versus...
Case-based learning on different aspects of transcatheter LAA closure
21 May 2025 – From EuroPCR 2025
Engage in case-based learning focused on transcatheter left atrial appendage (LAA) closure. This session covers safe transseptal puncture techniques, state-of-the-art standard LAA closure procedures, management of challenging LAA anatomies, and optimization of post-procedure antithrombotic therapy in high-risk patients.
Choices, choices: a global perspective on multiple modalities for calcium modification
21 May 2025 – From EuroPCR 2025
Gain a global perspective on multiple modalities for calcium modification in coronary interventions. This session reviews comparative analyses of orbital, shockwave, rotational atherectomy, and cutting balloons, explores evolving rotational atherectomy practices in the era of intravascular lithotripsy, and presents preliminary data from international registries on coronary...
Novel devices for edge-to-edge mitral repair
21 May 2025 – From EuroPCR 2025
Discover novel devices advancing transcatheter edge-to-edge mitral valve repair (TEER). This session presents clinical experiences with cost-effective and uniquely designed TEER systems for patients with degenerative mitral regurgitation and heart failure, including first-in-man applications and case series demonstrating safety and efficacy.
DCB PCI: are we ready for complex de novo lesions?
21 May 2025 – From EuroPCR 2025
Evaluate the readiness of drug-coated balloon (DCB) therapy for complex de novo coronary lesions. This session reviews comparative outcomes of DCB versus drug-eluting stents (DES) across CHIP risk categories, impacts of diabetes, long-term follow-up data in calcified lesions and left main bifurcations, and treatment of in-stent...
Management of high-risk left main lesion
21 May 2025 – From EuroPCR 2025
Focus on managing high-risk left main coronary lesions with this session featuring complex cases such as thrombotic lesions, calcified distal left main PCI with orbital atherectomy and IVUS guidance, and advanced stenting techniques. Learn practical approaches for challenging anatomical and clinical scenarios to optimize patient outcomes.
Metalfree PCI
21 May 2025 – From EuroPCR 2025
Explore metal-free PCI approaches emphasizing drug-coated balloon angioplasty and bioresorbable scaffold technologies. This session reviews angiographic outcomes in diffuse small vessel disease, bifurcation lesions, and acute myocardial infarction, alongside management strategies for restenosis post-DCB angioplasty, highlighting advancements in minimally invasive coronary interventions.
New evidence in the PFO closure
21 May 2025 – From EuroPCR 2025
Gain new insights into patent foramen ovale (PFO) closure with this session exploring age-related outcomes, risk of atrial arrhythmia, and patient selection improvements. Review various imaging approaches for assessing residual shunts and compare guidance techniques including TEE, fluoroscopy, and intracardiac echo from recent clinical registries.
Overcoming resistant lesions in NSTEMI
21 May 2025 – From EuroPCR 2025
Address the challenges of resistant lesions in NSTEMI with this focused session. Learn from complex cases involving thrombus management using Penumbra systems and Guideliner, as well as strategies to overcome extensive calcification through multiple interventional tools, illustrating a stepwise approach to tackling difficult coronary lesions.
